Searchable abstracts of presentations at key conferences in endocrinology

ea0090p600 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Mitochondrial fitness in mouse Leydig cells is imbalanced by liraglutide upon glucose stimuli

Lopes Bruno , Braga Patricia , Oliveira Pedro F. , Alves Marco , Bernardino Raquel

Metabolic diseases represent a threatening worldwide epidemic that affects the entire body. It is known that metabolic diseases, namely diabetes, and obesity affect spermatogenesis via suppressing testosterone synthesis, inducing oxidative stress and other changes that lead to decreased male fertility. Glucagon-like peptide 1 (GLP1) receptor agonists, like liraglutide, are pharmacological agents recommended to normalize glucose levels in patients with type 2 diabetes mellitus....

ea0090p325 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Insulin resistance and hyperglycemia induce mitochondrial dysfunction and a metabolic towards use of gluconeogenic amino acids in epithelial kidney cells

Braga Patricia , Bernardino Raquel , Guerra-Carvalho Barbara , Carrageta David F. , Rodrigues Anabela , Oliveira Pedro F. , Alves Marco

Diabetic nephropathy (DN) and insulin resistance (IR) in kidney cells are considered the main cause of end-stage renal failure. Additionally, hyperglycemia and increased fatty (FA) acids are observed in patients with type 2 diabetes mellitus, where lipid accumulation has been correlated to IR. Nonetheless, the impact of IR in early disease stages is still unclear. Moreover, proximal renal tubular cells have high mitochondrial content where aerobic respiration is their primary ...